News

Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...
Gabapentin is routinely used to treat nerve pain and restless leg syndrome, but it might be riskier to our brain health than ...
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...
Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?
A new study found that semaglutides like Ozempic are linked to a lower risk of Alzheimer's disease and dementia. Below, a ...
THEY’VE been hailed as miracle weight-loss jabs – but the effects of Ozempic-style drugs could go far beyond the waistline. New research suggests these so-called “skinny pens” may also ...
Weight loss drugs like Ozempic, while effective, are linked to significant side effects, leading many users to discontinue ...
Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new ...
Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.
A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health issues like dementia ...